Article

pubs.acs.org/joc

Brønsted Acid Catalyzed Asymmetric Diels−Alder Reactions:
Stereoselective Construction of Spiro[tetrahydrocarbazole-3,3′-
oxindole] Framework
Yang Wang,

Lei Yin, Meng Sun, and Feng Shi*

†

Man-Su Tu,

†

Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, School of Chemistry and Chemical Engineering,
Jiangsu Normal University, Xuzhou, 221116, China
*S Supporting Information

ABSTRACT: The chiral phosphoric acid catalyzed asymmet-
ric Diels−Alder reactions of 2-vinylindoles with methylenein-
dolinones have been established, which eﬃciently construct
the spiro[tetrahydrocarbazole-3,3′-oxindole] architecture with
one quaternary and three contiguous stereogenic centers in
high yields (up to 99%) and excellent stereoselectivities (up to
>95:5 dr, 97% ee). This reaction not only provides an eﬃcient strategy to access enantioenriched spiro[tetrahydrocarbazole-3,3′-
oxindoles] based on hydrogen-bonding activation mode but also supplies successful examples of catalytic asymmetric Diels−
Alder reactions for constructing complex spiro-frameworks with optical purity.

■ INTRODUCTION

Chiral
tetrahydrocarbazole and spirooxindole are privileged
structural motifs, which constitute the core structures of many
natural products and pharmacologically active compounds
(Figure 1).1 For example, (R)-ramatroban is a promising drug

tools to access structurally complex and diverse molecules with
potential bioactivity.3j Therefore, these two intriguing frame-
works of tetrahydrocarbazole and spirooxindole inspired us to
integrate them into a complex spiro[tetrahydrocarbazole-3,3′-
oxindole] scaﬀold bearing multiple substituents (Scheme 1),
Scheme 1. Design of Chiral Spiro[tetrahydrocarbazole-3,3′-
oxindole] Architecture

Figure 1. Selected compounds containing chiral tetrahydrocarbazole
and spirooxindole cores.

for the treatment of coronary artery disease.1b Besides, chiral
spirooxindoles showed versatile bioactivities such as antitumor-
al,1e anti-HIV,1f antimalarial,1g and antidiabetic1h activities. The
medicinal relevance of these two frameworks has incurred the
rapid development of the catalytic asymmetric approaches to
construct such enantioenriched scaﬀolds.2,3

In medicinal chemistry, it is reported that the incorporation
of two bioactive moieties into another unique and complex
structure may provide good opportunities
for obtaining
improved or new bioactivities.4 Besides, structure-based design
and diversity-oriented synthesis have proven to be powerful

which would provide a collection of promising compounds with
structural diversity for bioassay. Although elegant developments
have been achieved in the catalytic asymmetric transformations
leading to enantioselective spirooxindoles,3 the construction of
this type of complex spiro-framework with multiple stereogenic
centers has rarely been reported.5
Survey of the literature revealed that Melchiorre and co-
workers established a chiral amine-catalyzed asymmetric Diels−
Alder reaction of methyleneindolinones with heterocyclic ortho-
quinodimethanes (oQDMs) in situ generated from α,β-

Received:
January 28, 2015
Published: February 18, 2015

© 2015 American Chemical Society

3223

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
Scheme 2. Previous Work on Catalytic Asymmetric Construction of Spiro[tetrahydrocarbazole-3,3′-oxindole] Framework

Article

unsaturated aldehydes, which constructed a chiral spiro-
[tetrahydrocarbazole-3,3′-oxindole] scaﬀold in a highly stereo-
selective fashion (Scheme 2).5a In this work, oQDMs were
utilized as reactive diene species under aminocatalysis. In spite
of this creative work, the construction of an optically pure
spiro[tetrahydrocarbazole-3,3′-oxindole] architecture is still
rather limited. Therefore,
it is highly desirable to develop
more strategies to construct this fascinating structure based on
diﬀerent activation and disconnection modes.

Chiral phosphoric acids (CPAs) belong to a class of
privileged organocatalysts, which have enabled a variety of
enantioselective transformations.6 Moreover, 2-vinylindoles
have recently been utilized as dienes to participate in a number
of catalytic asymmetric Diels−Alder reactions or formal [4 + 2]
cycloadditions.7 However, this diene species has never been
employed to the Diels−Alder reactions with methyleneindoli-
nones8 to construct a spiro[tetrahydrocarbazole-3,3′-oxindole]
motif. On the basis of our previous works on CPA-catalyzed
enantioselective reactions,9 we envisioned that 2-vinylindoles
and methyleneindolinones could be simultaneously activated by
CPA via dual hydrogen-bonding activation to undergo
stereoselective Diels−Alder reaction/isomerization, thus con-
structing the desired enantioenriched spiro[tetrahydro-
carbazole-3,3′-oxindole] framework in a single transformation
(Scheme 3).
Herein, we report the CPA-catalyzed asymmetric Diels−
Alder reactions of 2-vinylindoles with methyleneindolinones,
which eﬃciently construct the chiral spiro[tetrahydrocarbazole-
3,3′-oxindole] architecture with three contiguous stereogenic
centers in excellent stereoselectivities (up to >95:5 dr, 97% ee).
■ RESULTS AND DISCUSSION
<para sub=“opt”>
Initially, the reaction of 2-vinylindole 1a and methyleneindo-
linone 2a catalyzed by 10 mol % of CPA 4a in toluene at 50 °C
was employed to testify our hypothesis (Table 1, entry 1),
which smoothly underwent the Diels−Alder reaction to aﬀord
the desired spiro[tetrahydrocarbazole-3,3′-oxindole] 3aa in a
high yield of 80% and a considerable stereoselectivity of >95:5
dr and 72% ee. Then, this reaction was utilized as a model
reaction to screen a variety of CPAs 4a−4g, which revealed that
catalysts 4e and 4g with bulky 3,3′-substituents on the BINOL
backbone delivered the highest enantioselectivity of 94% ee
(entries 5 and 7). Considering the higher yield of CPA 4g
</para>
Scheme 3. Design of CPA-Catalyzed Reaction to Construct
Chiral Spiro[tetrahydrocarbazole-3,3′-oxindole]
Architecture
<para sub=“opt”>
catalyzed reaction, this catalyst was selected as the optimal one
for further condition optimization. The screening of solvents
disclosed that no other types of solvents were better than
toluene in terms of enantioselective control (entries 8−14 vs
7). Then, variation of the reaction temperature (entries 15−17)
found that 25 °C was the most suitable condition, which
delivered the spiro-product 3aa in the highest yield of 96% and
the best stereoselectivity of >95:5 dr and 97% ee (entry 16).
Notably, when the catalyst loading was reduced to 5 mol %, the
reaction could also proceed in an eﬃcient mode with a high
yield and excellent stereoselectivity (entry 18).
</para>
<para sub="scope">
With the optimal conditions in hand, we investigated the
substrate scope of 2-vinylindoles 1 by the reactions with
methyleneindolinone 2a (Table 2). As shown in entries 1−7, a
variety of (E)-2-vinylindoles 1 linked with diﬀerent aryl groups
were applicable to the designed Diels−Alder reactions, which
generated the spiro[tetrahydrocarbazole-3,3′-oxindoles] 3
bearing three contiguous stereogenic centers in high yields
(87−96%) and excellent stereoselectivities (all >95:5 dr, 90−
97% ee) without exception. It seemed that the position of the
substituents linked to the phenyl ring imposed some eﬀect on
the enantioselectivity since para-methyl substituted substrate
1g oﬀered higher enantioselectivity than meta- and ortho-methyl
</para>
3224

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry

Table 1. Screening of Catalysts and Optimization of
Reaction Conditionsa

entry

solvent

T (°C)

yield (%)b

ee (%)d

cat.
4a
4b
4c
4d
4e
4f
4g
4g
4g
4g
4g
4g
4g
4g
4g
4g
4g
4g

drc
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
19:1
12:1
>95:5
>95:5
>95:5
>95:5

80
68
80
77
75
52
90
82
81
82
53
88
82
85
82
96
91
87

50
50
50
50
50
50
50
50
50
50
50
50
50
50
70
25
0
25

toluene
toluene
toluene
toluene
toluene
toluene
toluene
o-xylene
m-xylene
p-xylene
ClCH2CH2Cl
EtOAc
CH3CN
1,4-dioxane
toluene
toluene
toluene
toluene

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18e
aUnless otherwise indicated, the reaction was carried out at the 0.05
mmol scale and catalyzed by 10 mol % 4g in a solvent (0.2 mL) at T
°C for 15 h. The molar ratio of 1a:2a was 1:1.5. bIsolated yield. cThe
dr value was determined by 1H NMR and HPLC. dThe ee value was
determined by HPLC. e5 mol % 4g was used.

72
76
83
90
94
88
94
92
92
92
89
80
30
49
92
97
92
94

Article
<para sub="scope">
substituted counterparts 1e and 1c (entry 7 vs 5 and 3). In
most cases, there was no obvious diﬀerence between electron-
donating and electron-withdrawing groups
in terms of
stereoselectivity, because electronically diﬀerent substituents
at the same position delivered the reactions in similar diastereo-
and enantioselectivities (entry 4 vs 5, entry 6 vs 7). However, in
some cases, a strong electron-withdrawing group aﬀorded
higher enantioselectivity than an electron-donating group
(entry 2 vs 3). Notably, 2-vinylindole 1h linked with an
aliphatic methyl group could also be accommodated to the
Diels−Alder reaction, oﬀering spiro[tetrahydrocarbazole-3,3′-
oxindole] 3ha in a good yield of 82% and high
enantioselectivity of 90% ee, albeit with a decreased
diastereoselectivity of 80:20 dr (entry 8). However, the two
diastereomers could be easily separated by column chromatog-
raphy. Besides, substituted 2-vinylindoles as exempliﬁed by 5-
ﬂuoro-substituted substrate 1i, which could be synthesized from
commercially available starting materials, smoothly participated
in the Diels−Alder reaction in a high yield of 87% and an
excellent stereoselectivity of 92% ee and >95:5 dr (entry 9).
</para>
<para sub="scope">
Next,

the generality of

reaction for
methyleneindolinones 2 was studied by the reactions with 2-
vinylindoles 1. As illustrated in Table 3, this protocol was
amenable to a wide scope of methyleneindolinones 2 bearing
various R/R1/R2 substituents at diﬀerent positions of
the
moiety, giving structurally diverse spiro[tetrahydrocarbazole-
3,3′-oxindoles] 3 with one quaternary and three contiguous
stereogenic centers in generally high yields (65−99%) and
excellent diastereo- and enantioselectivities (all >95:5 dr, 81−
97% ee). First, the inﬂuence of N-substituents of the indolinone
motif was investigated by using substrates 2a−2e with N-alkyl,
N-benzyl, N-benzoyl, and N-H groups (entries 1−5), which
revealed that both N-protected and N-unprotected methyl-
eneindolinones 2 could successfully take part in the Diels−
Alder reactions to aﬀord the chiral spiro-products. Although N-
benzoyl substituted and N-unsubstituted substrates 2d−2e
were inferior to N-alkyl and N-benzyl substituted analogues
2a−2c with regard to the reactivity and the enantioselectivity
(entries 4−5 vs 1−3),
these
diﬀerent types of substrates greatly demonstrated the wide

the successful utilization of

the Diels−Alder
</para>

Table 2. Substrate Scope of 2-Vinylindoles 1a

entry

1
2
3
4
5
6
7
8
9

3
3aa
3ba
3ca
3da
3ea
3fa
3ga
3ha
3ia

R/R1 (1)
C6H5/H (1a)
o-FC6H4/H (1b)
o-MeC6H4/H (1c)
m-ClC6H4/H (1d)
m-MeC6H4/H (1e)
p-BrC6H4/H (1f)
p-MeC6H4/H (1g)
Me/H (1h)f
C6H5/F (1i)

yield (%)b
96 (87e)
93
89
87
90
94
90
82
87

drc

>95:5 (>95:5e)
>95:5
>95:5
>95:5
>95:5
>95:5
>95:5
80:20
>95:5

ee (%)d
97 (94e)
96
90
92
92
96
95
90
92

aUnless otherwise indicated, the reaction was carried out at the 0.05 mmol scale and catalyzed by 10 mol % 4g in toluene (0.2 mL) at 25 °C for 15 h.
The molar ratio of 1:2a was 1:1.5. bIsolated yield. cThe dr value was determined by 1H NMR. dThe ee value was determined by HPLC. eIn the
presence of 5 mol % 4g. fThe mixture of E/Z isomers (E/Z = 10:1) was employed to the reaction.

3225

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
Table 3. Substrate Scope of Methyleneindolinones 2a

Article
<para sub="scope">
form the corresponding spiro-product 3ar in a high yield of
93% and excellent stereoselectivity of >95:5 dr and 92% ee
(entry 18). Besides, the R2 group could also be changed to a
cyano group, and this substrate 2s smoothly participated in the
reaction in a considerable diastereo- and enantioselectivity
(entry 19).
</para>
<para sub=“props”>
The absolute conﬁguration of spiro[tetrahydrocarbazole-3,3′-
oxindole] 3ao (>99% ee after recrystallization) was unambig-
uously determined to be (2S,3R,4R) by single-crystal X-ray
diﬀraction analysis.10 The absolute conﬁguration of other spiro-
products 3 were assigned by analogy.
</para>
<para sub="scope">
In order to gain some insight into the activation mode of the
reaction, some control experiments were carried out under the
optimal conditions (Scheme 4). As shown in eq 1, N-methyl
</para>
Scheme 4. Control Experiments To Investigate the
Activation Mode
<para sub="scope">
protected 2-vinylindole 1j was utilized as a substrate instead of
N-unprotected substrate 1a, which could also aﬀord the
corresponding spiro-product 3ja but in an obviously diminished
yield and stereoselectivity. This result demonstrated that the N-
H group of 2-vinylindoles was very important for both the
reactivity and the stereoselectivity of the Diels−Alder reaction
by forming a hydrogen bond with the PO group of catalyst
4g. Furthermore, as mentioned above (Table 3, entries 1 and
4−5), changing the N-methyl group of substrates 2 to an N-
benzoyl or N-H group led to decreased enantioselectivities (eq
2). This phenomenon indicated that the N-benzoyl group of 2d
might compete with the amide group of the indolinone moiety
to form a hydrogen bond with CPA, and the N-H group of 2e
might also disturb the hydrogen-bonding interaction between
the N-H group of 1a and the catalyst, thus resulting in the
reduced enantioselectivities of spiro-products 3ad and 3ae.
</para>
<para sub="que">
On the basis of the experimental results, a possible transition
state illustrating the activation mode of
the reaction was
this chiral
suggested to explain the stereochemistry of
phosphoric acid catalyzed asymmetric Diels−Alder reaction.
As exempliﬁed by the generation of spiro-product 3aa (Scheme
5), CPA 4g acted as a Brønsted acid/Lewis base bifunctional
catalyst to simultaneously activate both the amide group of
methyleneindolinone and the N-H group of 2-vinylindole via
dual hydrogen-bonding interaction,11 which facilitated the
designed Diels−Alder reaction. The (R)-BINOL backbone of
the catalyst and the steric hindrance of its 3,3′-substitutents
created a chiral environment, which contributed greatly to the
excellent enantioselectivity obtained. Besides,
the terminal
phenyl group of (E)-2-vinylindole was oriented to the opposite
</para>
3226

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

aUnless otherwise indicated, the reaction was carried out at the 0.05
mmol scale and catalyzed by 10 mol % 4g in toluene (0.2 mL) at 25
°C for 15 h. The molar ratio of 1a:2 was 1:1.5. bIsolated yield. cThe dr
value was determined by 1H NMR. dThe ee value was determined by
HPLC. eIn the presence of 20 mol % 4g.

the impact of

this method. Second,
<para sub="scope">
applicability of
the
substituents R1 on the reaction was examined by employing a
wide range of substrates 2f−2q bearing electronically distinct
substituents at diﬀerent positions of the indolinone scaﬀold
(entries 6−17). The results disclosed that the electronic nature
and the position of the substituents at C5−C7 had no obvious
eﬀect on the stereoselectivity, because all of these substrates
uniformly aﬀorded the spiro[tetrahydrocarbazole-3,3′-oxin-
doles] 3 with structural diversity in excellent diastereo- and
enantioselectivities (entries 6−17, all >95:5 dr, 92−96% ee).
Finally, the R2 group of methyleneindolinones 2 could be
altered from an ester group to a ketone group, which also
successfully underwent the desired Diels−Alder reaction to
</para>
The Journal of Organic Chemistry
Scheme 5. Suggested Transition State of the Diels−Alder
Reaction
<para sub="scope">
Moreover,

some preliminary derivations of

the spiro-
products could be carried out. For example, the ester group
of product 3aa was easily transformed into an alcohol hydroxyl
functionality with retained diastereo- and enantioselectivity in a
high yield (eq 3).
</para>
<para sub=“ques”>
side of the benzene ring of the indolinone moiety, thus avoiding
the steric repulsion between them and leading to the perfect
diastereoselectivity experimentally observed. Therefore, an
eﬃcient and stereoselective Diels−Alder reaction occurred
under the catalysis of CPA 4g to aﬀord the spiro-product 3aa
with (2S,3R,4R)-conﬁguration.
</para>
■ CONCLUSIONS
In summary, we have established the chiral phosphoric acid
catalyzed asymmetric Diels−Alder reactions of 2-vinylindoles
with methyleneindolinones, which eﬃciently construct
the
spiro[tetrahydrocarbazole-3,3′-oxindole] architecture
chiral
with one quaternary and three contiguous stereogenic centers
in high yields (up to 99%) and excellent stereoselectivities (up
to >95:5 dr, 97% ee). This approach integrated biologically
important tetrahydrocarbazole and spirooxindole frameworks
into a new type of structurally complex spirooxindoles, which
would oﬀer a collection of promising compounds with
structural diversity for bioassay. This reaction not only provided
an eﬃcient strategy to access enantioenriched spiro[tetrahydro-
carbazole-3,3′-oxindoles] based on hydrogen-bonding activa-
tion mode but also supplied successful examples of catalytic
asymmetric Diels−Alder reactions for constructing complex
spiro-frameworks with optical purity.
■ EXPERIMENTAL SECTION
<para sub=“exp”>
General Information. 1H and 13C NMR spectra were measured at
400 and 100 MHz,
respectively. The solvent used for NMR
spectroscopy was CDCl3, using tetramethylsilane as the internal
reference. HRMS (ESI) was determined by a HRMS/MS instrument.
Enantiomeric excesses (ee) were determined by chiral high-perform-
ance liquid chromatography (chiral HPLC). The chiral columns used
for the determination of enantiomeric excesses by chiral HPLC were
Chiralpak IC, OD-H and IA columns. Optical rotation values were
measured with instruments operating at λ = 589 nm, corresponding to
the sodium D line at the temperatures indicated. Analytic grade
solvents for the chromatography and commercially available reagents
were used as received. Substrates 1 and 2 were synthesized according
to the literature methods.7d,8b Catalyst 4g was prepared according to
the procedures reported in the literature.12
Typical Procedure for Chiral Phosphoric Acid Catalyzed
Asymmetric Diels−Alder Reactions. Toluene (0.2 mL) was added
to the mixture of 2-vinylindoles 1 (0.05 mmol), methyleneindolinones
2 (0.075 mol), and the catalyst 4g (0.005 mmol). After being stirred at
25 °C for 15 h, the reaction mixture was concentrated under the
</para>
Article
<para sub=“exp”>
reduced pressure to give the residue, which was puriﬁed through
preparative thin layer chromatography to aﬀord pure products 3.
(2S,3R,4R)-Ethyl 1′-Methyl-2′-oxo-2-phenyl-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3aa). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 96% (21.7 mg); >95:5 dr; white solid; mp 215−216
°C; [α]D
20 = +56.5 (c 0.45, Acetone); 1H NMR (400 MHz, CDCl3) δ
8.04 (s, 1H), 7.43−7.40 (m, 1H), 7.36−7.30 (m, 2H), 7.13−7.01 (m,
8H), 6.94−7.89 (m, 1H), 6.56 (d, J = 8.0 Hz, 1H), 4.55−4.53 (m,
1H), 4.17−4.10 (m, 1H), 4.11−4.01 (m, 2H), 3.81 (dd, J = 16.1, 11.3
Hz, 1H), 3.15 (dd, J = 16.5, 5.6 Hz, 1H), 3.06 (s, 3H), 1.16 (t, J = 7.0
Hz, 3H); 13C NMR (400 MHz, CDCl3) δ 176.5, 172.4, 143.3, 140.1,
136.2, 135.6, 129.3, 128.6, 128.2, 127.7, 126.8, 126.8, 125.2, 121.8,
121.4, 119.5, 117.8, 110.7, 107.6, 104.7, 60.8, 52.1, 45.5, 43.0, 27.2,
25.9, 14.2; IR (KBr): 3647, 3056, 2963, 2925, 1706, 1710, 1493, 1458,
1261, 1030, 798, 746, 700 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 449.1860, found m/z 449.1857;
(C29H26N2O3
Enantiomeric excess: 97%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 10.48 min (major), tR = 8.00 min (minor).
(2R,3R,4R)-Ethyl 2-(2-Fluorophenyl)-1′-methyl-2′-oxo-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ba). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 93% (21.9 mg); >95:5 dr; white sticky oil;
20 = +90.5 (c 0.42, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.11
[α]D
(s, 1H), 7.44−7.36 (m, 2H), 7.31−7.26 (m, 1H), 7.18−7.09 (m, 3H),
7.08−6.99 (m, 2H), 6.94−6.82 (m, 2H), 6.78 (t, J = 9.2 Hz, 1H), 6.60
(d, J = 7.8 Hz, 1H), 5.00 (s, 1H), 4.18−3.99 (m, 3H), 3.68−3.62 (m,
1H), 3.16−3.05 (m, 4H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 176.6, 172.0, 143.2, 136.3, 135.1, 129.1, 128.4, 128.4,
127.7, 127.6, 126.8, 125.1, 125.0, 123.8, 123.7, 122.1, 121.5, 119.5,
118.1, 115.0, 114.8, 110.8, 107.5, 104.9, 60.8, 52.1, 45.5, 33.5, 26.7,
26.0, 14.1; IR (KBr): 3677, 3649, 3630, 1670, 1522, 1288, 1262, 1177,
1093, 1029, 817 cm−1; ESI FTMS exact mass calcd for (C29H25FN2O3
− H)− requires m/z 467.1765, found m/z 467.1773; Enantiomeric
excess: 96%, determined by HPLC (Daicel Chirapak IA, hexane/
isopropanol = 70/30, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR =
15.16 min (major), tR = 13.85 min (minor).
(2S,3R,4R)-Ethyl 1′-Methyl-2′-oxo-2-(o-tolyl)-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ca). Prep-
arative thin layer chromatography: Toluene/ethyl acetate = 8/1;
Reaction time = 15 h; yield: 89% (20.9 mg); >95:5 dr; white sticky oil;
20 = +109.0 (c 0.50, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.06
[α]D
(s, 1H), 7.43 (d, J = 8.0 Hz, 1H), 7.33 (d, J = 7.0 Hz, 1H), 7.29−7.27
(m, 1H), 7.15−7.09 (m, 3H), 7.07−7.02 (m, 1H), 6.98−6.90 (m, 3H),
6.89−6.82 (m, 1H), 6.63 (d, J = 8.0 Hz, 1H), 5.06−5.02 (m, 1H),
4.19−4.12 (m, 1H), 4.11−4.01 (m, 2H), 3.64 (dd, J = 16.5, 10.9 Hz,
1H), 3.16 (s, 3H), 3.05 (dd, J = 16.6, 5.6 Hz, 1H), 2.39 (s, 3H), 1.17
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 177.0, 172.6,
143.3, 139.4, 136.2, 136.2, 135.9, 130.2, 129.6, 128.3, 126.8, 126.5,
125.8, 125.6, 124.3, 121.8, 121.4, 119.5, 117.9, 110.8, 107.7, 104.7,
60.8, 52.1, 45.9, 37.2, 27.9, 26.1, 20.3, 14.2; IR (KBr): 3650, 1734,
1717, 1672, 1648, 1542, 1508, 1364, 1339, 1262, 807 cm−1; ESI FTMS
− H)− requires m/z 463.2016,
exact mass calcd for (C30H28N2O3
found m/z 463.2016; Enantiomeric excess: 90%, determined by HPLC
(Daicel Chirapak IA, hexane/isopropanol = 70/30, ﬂow rate 1.0 mL/
min, T = 30 °C, 254 nm): tR = 16.69 min (major), tR = 13.91 min
(minor).
(2S,3R,4R)-Ethyl 2-(3-Chlorophenyl)-1′-methyl-2′-oxo-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3da). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 87% (21.2 mg); >95:5 dr; white sticky oil;
20 = +21.0 (c 0.38, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.03
[α]D
(s, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.16−7.04
(m, 4H), 7.02−6.91 (m, 4H), 6.59 (d, J = 8.0 Hz, 1H), 4.59−4.52 (m,
1H), 4.20−4.13 (m, 1H), 4.10−4.01 (m, 2H), 3.77 (dd, J = 16.4, 11.2
Hz, 1H), 3.16−3.06 (m, 4H), 1.16 (t, J = 7.2 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 176.2, 172.4, 143.2, 142.3, 136.2, 135.1, 133.6, 129.0,
128.9, 128.6, 128.5, 127.0, 126.9, 126.8, 125.2, 122.1, 121.5, 119.6,
117.9, 110.8, 107.9, 104.7, 60.9, 51.9, 45.5, 42.8, 27.1, 25.9, 14.2; IR
</para>
3227

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
<para sub=“exp”>
(KBr): 3691, 3677, 3650, 1801, 1718, 1700, 1508, 1458, 1262, 795
− H)− requires
cm−1; ESI FTMS exact mass calcd for (C29H25ClN2O3
m/z 483.1470,
found m/z 483.1469; Enantiomeric excess: 92%,
determined by HPLC (Daicel Chirapak OD-H, hexane/isopropanol =
85/15, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 10.46 min
(major), tR = 7.85 min (minor).
(2S,3R,4R)-Ethyl 1′-Methyl-2′-oxo-2-(m-tolyl)-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ea). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 90% (20.9 mg); >95:5 dr; white sticky oil; [α]D
20 =
+56.2 (c 0.42, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.05 (s, 1H),
7.41 (d, J = 8.0 Hz, 1H), 7.31 (dd, J = 15.0, 8.0 Hz, 2H), 7.12−7.02
(m, 3H), 6.94−6.80 (m, 5H), 6.56 (d, J = 8.0 Hz, 1H), 4.54−4.50 (m,
1H), 4.16−4.13 (m, 1H), 4.11−4.00 (m, 2H), 3.80 (dd, J = 16.5, 11.2
Hz, 1H), 3.18−3.07 (m, 1H), 3.07 (s, 3H), 2.14 (s, 3H), 1.16 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.6, 172.5, 143.3,
140.0, 137.3, 136.2, 135.7, 129.5, 129.3, 128.2, 127.6, 127.5, 126.9,
125.6, 125.3, 121.8, 121.3, 119.4, 117.8, 110.8, 107.6, 104.7, 60.8, 52.1,
45.6, 43.0, 27.2, 25.9, 21.3, 14.2; IR (KBr): 3677, 3650, 1734, 1685,
1654, 1508, 1318, 1265, 1156, 1090, 1029, 744 cm−1; ESI FTMS exact
− H)− requires m/z 463.2016, found m/z
mass calcd for (C30H28N2O3
463.2014; Enantiomeric excess: 92%, determined by HPLC (Daicel
Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min,
T = 30 °C, 254 nm): tR = 9.77 min (major), tR = 7.20 min (minor).
(2S,3R,4R)-Ethyl 2-(4-Bromophenyl)-1′-methyl-2′-oxo-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3fa). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 94% (24.8 mg); >95:5 dr; yellow sticky
20 = +12.8 (c 0.47, Acetone); 1H NMR (400 MHz, CDCl3) δ
oil; [α]D
8.01 (s, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.19−
7.11 (m, 4H), 7.08−7.02 (m, 1H), 6.98−6.90 (m, 3H), 6.61 (d, J = 8.0
Hz, 1H), 4.55−4.51 (m, 1H), 4.16−4.14 (m, 1H), 4.07−3.99 (m, 2H),
3.75 (dd, J = 16.5, 11.0 Hz, 1H), 3.17−3.10 (m, 1H), 3.08 (s, 3H),
1.15 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.3, 172.4,
143.2, 139.3, 136.2, 135.1, 130.9, 130.3, 129.0, 128.5, 126.8, 125.1,
122.0, 121.6, 120.7, 119.6, 117.9, 110.8, 108.0, 104.7, 60.8, 52.0, 45.5,
42.4, 27.2, 26.0, 14.2; IR (KBr): 3677, 3649, 3628, 1799, 1728, 1687,
1524, 1163, 1109, 745 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 527.0965, found m/z 527.0969;
(C29H25BrN2O3
Enantiomeric excess: 96%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 12.22 min (major), tR = 9.36 min (minor).
(2S,3R,4R)-Ethyl 1′-Methyl-2′-oxo-2-(p-tolyl)-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ga). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 90% (21.0 mg); >95:5 dr; white sticky oil; [α]D
20 =
+102.1 (c 0.28, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.06 (s,
1H), 7.41 (d, J = 8.0 Hz, 1H), 7.33 (d, J = 7.6 Hz, 1H), 7.30−7.27 (m,
1H), 7.13−7.09 (m, 2H), 7.07−7.03 (m, 1H), 6.98−6.89 (m, 3H),
6.90−6.83 (m, 2H), 6.59 (d, J = 8.0 Hz, 1H), 4.50−4.46 (m, 1H),
4.20−4.10 (m, 1H), 4.10−3.99 (m, 2H), 3.76 (dd, J = 16.5, 10.9 Hz,
1H), 3.16−3.02 (m, 4H), 2.17 (s, 3H), 1.15 (t, J = 7.0 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ 176.7, 172.5, 143.3, 137.1, 136.3, 136.2,
135.7, 129.5, 128.5, 128.4, 128.1, 126.9, 125.2, 121.8, 121.4, 119.4,
117.9, 110.8, 107.7, 104.7, 60.8, 52.2, 45.6, 42.6, 27.5, 25.9, 20.9, 14.2;
IR (KBr): 3677, 3650, 3630, 1733, 1670, 1648, 1569, 1261, 1236,
1091, 1029, 802, 743 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 463.2016, found m/z 463.2016;
(C30H28N2O3
Enantiomeric excess: 95%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 10.88 min (major), tR = 7.75 min (minor).
(2R,3R,4R)-Ethyl 1′,2-Dimethyl-2′-oxo-1,2,4,9-tetrahydro-
spiro[carbazole-3,3′-indoline]-4-carboxylate (3ha). Preparative
thin layer chromatography: pure dichloromethane; Reaction time = 15
h; yield: 82% (16.1 mg); 80:20 dr; white sticky oil; [α]D
20 = +19.1 (c
0.88, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.07 (s, 1H), 7.37 (d, J
= 8.0 Hz, 1H), 7.32−7.28 (m, 2H), 7.22 (d, J = 7.6 Hz, 1H), 7.10−
7.06 (m, 1H), 7.05−6.95 (m, 2H), 6.87 (d, J = 8.0 Hz, 1H), 4.17 (s,
1H), 3.97−3.92 (m, 2H), 3.21 (s, 3H), 3.07−2.84 (m, 3H), 1.00 (t, J =
7.2 Hz, 3H), 0.92−0.89 (m, 3H); 13C NMR (100 MHz, CDCl3) δ
</para>
Article
<para sub=“exp”>
177.2, 171.9, 143.9, 136.2, 134.6, 130.3, 128.4, 127.0, 124.8, 122.2,
121.3, 119.4, 118.4, 110.7, 107.9, 104.7, 60.6, 52.5, 44.4, 32.1, 28.2,
26.2, 16.0, 14.0; IR (KBr): 3677, 3650, 3079, 3050, 2930, 1734, 1699,
1647, 1457, 1094, 1023, 800, 746 cm−1; ESI FTMS exact mass calcd
− H)− requires m/z 387.1703, found m/z 387.1713;
for (C24H24N2O3
Enantiomeric excess: 90%, determined by HPLC (Daicel Chirapak IA,
hexane/isopropanol = 70/30, ﬂow rate 1.0 mL/min, T = 30 °C, 254
nm): tR = 9.85 min (major), tR = 7.73 min (minor).
(2S,3R,4R)-Ethyl 6-Fluoro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ia). Preparative thin layer chromatography: petroleum ether/ethyl
acetate = 3/1; Reaction time = 15 h; yield: 87% (20.5 mg); >95:5 dr;
white sticky oil; [α]D
20 = +56.9 (c 0.43, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.18 (s, 1H), 7.34 (d, J = 7.6 Hz, 1H), 7.17−6.97 (m, 8H),
6.94−6.84 (m, 1H), 6.82−6.77 (m, 1H), 6.56 (d, J = 8.0 Hz, 1H),
4.57−4.53 (m, 1H), 4.23−4.06 (m, 2H), 4.01 (s, 1H), 3.80 (dd, J =
16.4, 11.2 Hz, 1H), 3.17−3.02 (m, 4H), 1.17 (t, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ 176.6, 172.4, 143.2, 139.9, 137.6, 132.6,
129.1, 128.6, 128.3, 127.8, 126.9, 125.3, 122.0, 111.4, 109.4, 109.2,
107.8, 104.8, 103.1, 60.9, 52.1, 45.4, 42.9, 27.3, 26.0, 14.2; IR (KBr):
3675 3651, 3309, 3100, 1763, 1652, 1311, 1099, 1011, 749, 677 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C29H25FN2O3
467.1766, found m/z 467.1768; Enantiomeric excess: 92%, determined
by HPLC (Daicel Chirapak IC, hexane/isopropanol = 70/30, ﬂow rate
1.0 mL/min, T = 30 °C, 254 nm): tR = 7.69 min (major), tR = 4.33
min (minor).
(2S,3R,4R)-Ethyl 1′-Ethyl-2′-oxo-2-phenyl-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ab). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 95% (22.2 mg); >95:5 dr; white solid; mp 200−202
°C; [α]D
20 = +92.7 (c 0.42, Acetone); 1H NMR (400 MHz, CDCl3) δ
8.12 (s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 7.6 Hz, 1H), 7.29−
7.27 (m, 1H), 7.22−6.99 (m, 8H), 6.96−6.87 (m, 1H), 6.59 (d, J = 8.0
Hz, 1H), 4.55−4.51 (m, 1H), 4.17−4.11 (m, 1H), 4.09−3.98 (m, 2H),
3.77−3.68 (m, 2H), 3.57−3.50 (m, 1H), 3.12 (dd, J = 16.6, 5.8 Hz,
1H), 1.19−1.11 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 176.2,
172.5, 142.4, 140.1, 136.2, 135.7, 129.5, 128.9, 128.1, 127.8, 126.8,
126.8, 125.5, 121.6, 121.4, 119.4, 117.8, 110.8, 107.8, 104.6, 60.8, 52.0,
45.7, 42.9, 34.4, 27.2, 14.2, 12.2; IR (KBr): 3650, 3057, 2964, 2929,
1734, 1717, 1647, 1430, 1262, 801, 745, 702 cm−1; ESI FTMS exact
− H)− requires m/z 463.2016, found m/z
mass calcd for (C30H28N2O3
463.2015; Enantiomeric excess: 90%, determined by HPLC (Daicel
Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min,
T = 30 °C, 254 nm): tR = 9.41 min (major), tR = 6.78 min (minor).
(2S,3R,4R)-Ethyl 1′-Benzyl-2′-oxo-2-phenyl-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ac). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 93% (24.6 mg); >95:5 dr; yellow sticky oil; [α]D
20 =
+48.3 (c 0.59, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.12 (s, 1H),
7.46−7.34 (m, 3H), 7.29−7.27 (m, 2H), 7.20−6.96 (m, 11H), 6.92−
6.88 (m, 1H), 6.54 (d, J = 8.0 Hz, 1H), 4.87 (d, J = 15.6 Hz, 1H), 4.73
(d, J = 15.6 Hz, 1H), 4.62−4.58 (m, 1H), 4.22−4.10 (m, 2H), 4.07−
3.98 (m, 1H), 3.83 (dd, J = 16.4, 11.0 Hz, 1H), 3.13 (dd, J = 16.6, 5.8
Hz, 1H), 1.14 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
176.7, 172.4, 142.6, 140.1, 136.2, 135.7, 135.7, 129.3, 128.9, 128.6,
128.2, 128.0, 127.6, 127.5, 126.8, 125.5, 121.9, 121.4, 119.5, 117.9,
110.9, 108.8, 104.5, 60.9, 52.3, 46.2, 43.7, 42.7, 27.3, 14.2; IR (KBr):
3650, 3057, 3032, 2963, 2917, 2849, 1732, 1700, 1686, 1019, 801, 748,
− H)−
701 cm−1; ESI FTMS exact mass calcd for (C35H30N2O3
requires m/z 525.2173, found m/z 525.2183; Enantiomeric excess:
92%, determined by HPLC (Daicel Chirapak OD-H, hexane/
isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm):
tR = 10.07 min (major), tR = 13.74 min (minor).
(2S,3R,4R)-Ethyl 1′-Benzoyl-2′-oxo-2-phenyl-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ad). Prep-
arative thin layer chromatography: pure dichloromethane; Reaction
time = 15 h; yield: 65% (17.7 mg); >95:5 dr; pale yellow sticky oil;
20 = +57.9 (c 0.44, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.00
[α]D
(s, 1H), 7.66 (d, J = 7.6 Hz, 2H), 7.57 (d, J = 8.0 Hz, 1H), 7.52−7.48
(m, 1H), 7.46−7.35 (m, 4H), 7.28−7.26 (m, 1H), 7.23−7.18 (m, 2H),
</para>
3228

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
<para sub=“exp”>
7.17−7.06 (m, 7H), 4.51−4.47 (m, 1H), 4.34−4.32 (m, 1H), 4.19−
4.10 (m, 1H), 4.08−3.92 (m, 1H), 3.64−3.59 (m, 1H), 3.19 (dd, J =
16.8, 6.0 Hz, 1H), 1.12 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 175.8, 171.7, 169.4, 139.8, 139.7, 136.2, 135.2, 134.3, 132.8,
129.2, 129.0, 128.7, 128.6, 128.3, 128.2, 127.4, 126.7, 125.4, 124.2,
121.6, 119.6, 117.9, 114.6, 110.9, 104.3, 61.1, 53.1, 46.6, 43.3, 27.2,
14.1; IR (KBr): 3650, 2962, 2901, 1717, 1654, 1262, 1024, 801, 743,
− H)−
669 cm−1; ESI FTMS exact mass calcd for (C35H28N2O4
requires m/z 539.1965, found m/z 539.1977; Enantiomeric excess:
80%, determined by HPLC (Daicel Chirapak IC, hexane/isopropanol
= 70/30, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 5.13 min
(minor), tR = 6.08 min (major).
(2S,3R,4R)-Ethyl 2′-Oxo-2-phenyl-1,2,4,9-tetrahydrospiro-
[carbazole-3,3′-indoline]-4-carboxylate (3ae). Preparative thin
layer chromatography: Toluene/ethyl acetate = 8/1; Reaction time =
15 h; yield: 88% (19.3 mg); >95:5 dr; white sticky oil; [α]D
20 = +63.0 (c
0.42, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.86−
7.79 (m, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.31−7.28 (m, 2H), 7.25−6.94
(m, 8H), 6.89−6.85 (m, 1H), 6.51 (d, J = 8.0 Hz, 1H), 4.52−4.47 (m,
1H), 4.19−4.08 (m, 2H), 4.08−3.98 (m, 1H), 3.78−3.72 (m, 1H),
3.15 (dd, J = 16.6, 5.6 Hz, 1H), 1.12 (t, J = 7.2 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 178.6, 172.3, 140.2, 136.2, 135.4, 129.8, 128.7,
128.2, 128.0, 126.9, 126.9, 125.7, 121.8, 121.5, 119.5, 118.0, 110.9,
109.4, 104.6, 60.8, 52.7, 45.6, 43.0, 27.3, 14.1; IR (KBr): 3647, 3031,
2961, 2920, 1721, 1715, 1688, 1605, 1207, 1117, 803, 745, 702 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C28H24N2O3
435.1703, found m/z 435.1712; Enantiomeric excess: 82%, determined
by HPLC (Daicel Chirapak IA, hexane/isopropanol = 70/30, ﬂow rate
1.0 mL/min, T = 30 °C, 254 nm): tR = 25.17 min (major), tR = 16.55
min (minor).
(2S,3R,4R)-Ethyl 5′-Fluoro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3af). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 83% (19.6 mg); >95:5 dr; white sticky oil;
20 = +72.2 (c 0.47, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.05
[α]D
(s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H), 7.20−6.96
(m, 8H), 6.88−6.75 (m, 1H), 6.46 (dd, J = 8.4, 4.2 Hz, 1H), 4.57−
4.53 (m, 1H), 4.23−4.04 (m, 3H), 3.81−3.77 (m, 1H), 3.14 (dd, J =
16.6, 5.8 Hz, 1H), 3.08−2.98 (m, 3H), 1.19 (t, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ 176.0, 172.3, 139.7, 139.3, 136.2, 135.5,
128.6, 127.9, 127.0, 126.7, 121.5, 119.6, 117.9, 114.5, 114.3, 113.7,
113.4, 110.8, 108.1, 104.4, 61.0, 52.6, 45.5, 43.0, 27.2, 26.0, 14.2; IR
(KBr): 3651, 3049, 2971, 2963, 1665, 1272, 1015, 804, 749, 700 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C29H25FN2O3
467.1765, found m/z 467.1765; Enantiomeric excess: 96%, determined
by HPLC (Daicel Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow
rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 11.58 min (major), tR =
8.40 min (minor).
(2S,3R,4R)-Ethyl 5′-Chloro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ag). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 95% (23.0 mg); >95:5 dr; white solid; mp
296−298 °C; [α]D
20 = +112.7 (c 0.43, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.06 (s, 1H), 7.42−7.38 (m, 1H), 7.36−7.33 (m, 1H), 7.31
(d, J = 8.0 Hz, 1H), 7.17−6.99 (m, 8H), 6.47 (d, J = 8.4 Hz, 1H),
4.55−4.48 (m, 1H), 4.25−4.12 (m, 2H), 4.06 (s, 1H), 3.82−3.75 (m,
1H), 3.14 (dd, J = 16.6, 5.8 Hz, 1H), 3.04 (s, 3H), 1.20 (t, J = 7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 176.0, 172.3, 141.9, 139.6,
136.2, 135.5, 131.0, 128.6, 128.1, 128.0, 127.4, 127.0, 126.7, 125.7,
121.5, 119.6, 117.8, 110.8, 108.6, 104.3, 61.1, 52.4, 45.4, 43.0, 27.1,
26.0, 14.2; IR (KBr): 3649, 3599, 2962, 1685, 1647, 1261, 1151, 1095,
1019, 799, 741, 705 cm−1; ESI FTMS exact mass calcd for
(C29H25ClN2O3
found m/z
483.1474; Enantiomeric excess: 95%, determined by HPLC (Daicel
Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min,
T = 30 °C, 254 nm): tR = 12.01 min (major), tR = 8.78 min (minor).
(2S,3R,4R)-Ethyl 5′-Bromo-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ah). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 93% (24.7 mg); >95:5 dr; pale yellow

− H)− requires m/z 483.1470,
</para>
Article
<para sub=“exp”>
solid; mp 285−286 °C; [α]D
20 = +99.3 (c 0.43, Acetone); 1H NMR
(400 MHz, CDCl3) δ 8.07 (s, 1H), 7.49−7.46 (m, 1H), 7.40 (d, J =
8.0 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 7.25−7.20 (m, 1H), 7.16−7.03
(m, 7H), 6.42 (d, J = 8.4 Hz, 1H), 4.53−4.48 (m, 1H), 4.20−4.12 (m,
2H), 4.06 (s, 1H), 3.79 (dd, J = 16.4, 11.0 Hz, 1H), 3.13 (dd, J = 16.4,
5.8 Hz, 1H), 3.03 (s, 3H), 1.21 (t, J = 7.2 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 175.9, 172.3, 142.3, 139.6, 136.2, 135.5, 131.4, 131.0,
128.6, 128.4, 128.0, 127.0, 126.7, 121.5, 119.6, 117.7, 114.6, 110.9,
109.1, 104.3, 61.1, 52.4, 45.4, 43.0, 27.1, 26.0, 14.3; IR (KBr): 3691,
3651, 2963, 1699, 1686, 1340, 1263, 1098, 1022, 806, 743, 703 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C29H25BrN2O3
527.0965, found m/z 527.0967; Enantiomeric excess: 96%, determined
by HPLC (Daicel Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow
rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 12.08 min (major), tR =
8.45 min (minor).
(2S,3R,4R)-Ethyl 1′,5′-Dimethyl-2′-oxo-2-phenyl-1,2,4,9-
tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ai).
Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 96% (22.4 mg); >95:5 dr; white solid;
mp 289−291 °C; [α]D
20 = +112.7 (c 0.44, Acetone); 1H NMR (400
MHz, CDCl3) δ 8.11 (s, 1H), 7.41 (d, J = 7.6 Hz, 1H), 7.28 (d, J = 7.2
Hz, 1H), 7.12−7.02 (m, 8H), 6.90 (d, J = 8.0 Hz, 1H), 6.45 (d, J = 8.0
Hz, 1H), 4.52−4.44 (m, 1H), 4.22−4.01 (m, 3H), 3.79−3.73 (m, 1H),
3.11 (dd, J = 16.4, 5.6 Hz, 1H), 3.05 (s, 3H), 2.26 (s, 3H), 1.16 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.5, 172.6, 140.9,
140.3, 136.2, 135.6, 131.2, 129.3, 128.6, 128.4, 127.8, 126.9, 126.8,
126.0, 121.4, 119.4, 117.8, 110.8, 107.4, 104.7, 60.7, 52.2, 45.6, 43.1,
27.3, 26.0, 21.2, 14.2; IR (KBr): 3691, 3677, 3651, 2962, 1685, 1559,
1263, 1176, 1024, 817, 753, 709 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 463.2016, found m/z 463.2009;
(C30H28N2O3
Enantiomeric excess: 96%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 9.33 min (major), tR = 7.11 min (minor).
(2S,3R,4R)-Ethyl 5′-Methoxy-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3aj). Preparative thin layer chromatography: petroleum ether/ethyl
acetate = 3/1; Reaction time = 15 h; yield: 86% (20.6 mg); >95:5 dr;
white sticky oil; [α]D
20 = +96.9 (c 0.29, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.09 (s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.31−7.27 (m, 1H),
7.14−6.97 (m, 8H), 6.67−6.60 (m, 1H), 6.45 (d, J = 8.4 Hz, 1H),
4.55−4.50 (m, 1H), 4.24−4.13 (m, 1H), 4.10−3.92 (m, 2H), 3.80 (dd,
J = 16.4, 11.2 Hz, 1H), 3.74 (s, 3H), 3.11 (dd, J = 16.4, 6.0 Hz, 1H),
3.04 (s, 3H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
176.3, 172.5, 155.5, 140.2, 137.0, 136.2, 135.6, 130.6, 128.6, 127.8,
126.8, 121.4, 119.4, 117.8, 112.9, 112.8, 110.8, 107.9, 104.6, 60.8, 56.0,
52.5, 45.7, 43.0, 27.4, 26.0, 14.2; IR (KBr): 3648, 3566, 3347, 2963,
1730, 1700, 1654, 1625, 1497, 1458, 1261, 1031, 809, 737, 705 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C30H28N2O4
479.1965 found m/z 479.1972; Enantiomeric excess: 96%, determined
by HPLC (Daicel Chirapak IC, hexane/isopropanol = 70/30, ﬂow rate
1.0 mL/min, T = 30 °C, 254 nm): tR = 24.65 min (major), tR = 6.30
min (minor).
(2S,3R,4R)-Ethyl 6′-Chloro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ak). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 92% (22.4 mg); >95:5 dr; white solid; mp
281−283 °C; [α]D
20 = +73.9 (c 0.36, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.07 (s, 1H), 7.44−7.39 (m, 1H), 7.29−7.27 (m, 1H),
7.14−7.02 (m, 8H), 6.92−6.86 (m, 1H), 6.58−6.54 (m, 1H), 4.58−
4.50 (m, 1H), 4.22−4.16 (m, 1H), 4.08−4.00 (m, 2H), 3.80−3.72 (m,
1H), 3.12 (dd, J = 16.8, 6.0 Hz, 1H), 3.04 (s, 3H), 1.18 (t, J = 7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 176.5, 172.4, 144.6, 139.8,
136.2, 135.5, 134.0, 128.5, 128.0, 127.8, 127.3, 127.1, 126.7, 126.4,
123.4, 121.7, 121.5, 121.3, 119.6, 117.8, 114.7, 112.4, 110.8, 108.5,
104.3, 61.0, 52.0, 45.5, 42.9, 27.2, 26.0, 14.2; IR (KBr): 3650, 3630,
2963, 1717, 1685, 1543, 1374, 1262, 1076, 1019, 800, 745, 697 cm−1;
− H)− requires m/z
ESI FTMS exact mass calcd for (C29H25ClN2O3
483.1470, found m/z 483.1470; Enantiomeric excess: 94%, determined
by HPLC (Daicel Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow
</para>
3229

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
<para sub=“exp”>
rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 11.02 min (major), tR =
8.41 min (minor).
(2S,3R,4R)-Ethyl 6′-Methoxy-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3al). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 71% (17.1 mg); >95:5 dr; white sticky oil;
20 = +68.1 (c 0.43, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.06
[α]D
(s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.30−7.27 (m, 1H), 7.22 (d, J = 8.4
Hz, 1H), 7.15−7.00 (m, 7H), 6.43−6.38 (m, 1H), 6.18−6.10 (m, 1H),
4.55−4.47 (m, 1H), 4.21−4.13 (m, 1H), 4.10−4.00 (m, 2H), 3.83−
3.70 (m, 4H), 3.11 (dd, J = 16.4, 5.6 Hz, 1H), 3.04 (s, 3H), 1.18 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 177.1, 172.6, 160.0,
144.6, 140.3, 136.2, 135.6, 128.6, 127.8, 126.8, 126.8, 126.0, 121.4,
121.2, 119.4, 117.9, 110.8, 105.8, 104.8, 95.5, 60.8, 55.3, 51.8, 45.8,
43.2, 27.3, 25.9, 14.3; IR (KBr): 3691, 3650, 3630, 1718, 1685, 1489,
1265, 1093, 1019, 743, 701 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 479.1965, found m/z 479.1967;
(C30H28N2O4
Enantiomeric excess: 92%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 12.37 min (major), tR = 9.92 min (minor).
(2S,3R,4R)-Ethyl 7′-Fluoro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3am). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 99% (23.1 mg); >95:5 dr; white solid; mp
241−243 °C; [α]D
20 = +100.9 (c 0.33, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.08 (s, 1H), 7.44−7.38 (m, 1H), 7.30−7.27 (m, 1H),
7.17−7.02 (m, 8H), 6.87−6.80 (m, 2H), 4.56−4.48 (m, 1H), 4.20−
4.14 (m, 1H), 4.09−3.98 (m, 2H), 3.78 (dd, J = 16.4, 11.2 Hz, 1H),
3.31−3.28 (m, 3H), 3.12 (dd, J = 16.4, 6.0 Hz, 1H), 1.17 (t, J = 7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 176.2, 172.3, 148.5, 146.1,
139.8, 136.2, 135.5, 132.2, 130.2, 130.1, 128.5, 127.9, 127.3, 127.1,
126.7, 123.4, 122.3, 122.2, 121.5, 121.3, 121.2, 121.1, 119.5, 117.8,
116.3, 116.1, 114.7, 112.4, 110.8, 104.3, 60.9, 52.5, 45.7, 43.1, 28.4,
28.4, 27.2, 14.2; IR (KBr): 3649, 3619, 1685, 1558, 1240, 1176, 1017,
802, 744, 703, 669 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 467.1765, found m/z 467.1767;
(C29H25FN2O3
Enantiomeric excess: 92%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 7.96 min (major), tR = 6.32 min (minor).
(2S,3R,4R)-Ethyl 7′-Chloro-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3an). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 90% (21.7 mg); >95:5 dr; white sticky oil;
20 = +72.8 (c 0.55, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.10
[α]D
(s, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.30−7.27 (m, 1H), 7.25−7.22 (m,
1H), 7.17−7.00 (m, 8H), 6.82 (t, J = 8.0 Hz, 1H), 4.54−4.42 (m, 1H),
4.19−4.13 (m, 1H), 4.09−3.99 (m, 2H), 3.76 (dd, J = 16.4, 11.2 Hz,
1H), 3.47 (s, 3H), 3.12 (dd, J = 16.4, 6.0 Hz, 1H), 1.16 (t, J = 7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 176.8, 172.3, 139.8, 139.3,
136.2, 135.5, 132.1, 130.6, 128.5, 128.0, 127.1, 126.7, 123.8, 122.5,
121.5, 119.5, 117.8, 115.1, 110.9, 104.4, 60.9, 51.9, 45.9, 43.1, 29.4,
27.4, 14.2; IR (KBr): 3676, 3650, 1717, 1639, 1508, 1155, 1094, 837,
− H)−
744, 672 cm−1; ESI FTMS exact mass calcd for (C29H25ClN2O3
requires m/z 483.1470, found m/z 483.1462; Enantiomeric excess:
96%, determined by HPLC (Daicel Chirapak OD-H, hexane/
isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm):
tR = 8.07 min (major), tR = 6.78 min (minor).
(2S,3R,4R)-Ethyl 7′-Bromo-1′-methyl-2′-oxo-2-phenyl-
1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate
(3ao). Preparative thin layer chromatography: pure dichloromethane;
Reaction time = 15 h; yield: 88% (23.4 mg); >95:5 dr; white solid; mp
226−228 °C; [α]D
20 = +67.4 (c 0.47, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.09 (s, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.31−7.27 (m, 2H),
7.24−7.20 (m, 1H), 7.15−7.03 (m, 7H), 6.75 (t, J = 8.0 Hz, 1H),
4.51−4.43 (m, 1H), 4.16−4.11 (m, 1H), 4.09−3.98 (m, 2H), 3.75−
3.71 (m, 1H), 3.48 (s, 3H), 3.13 (dd, J = 16.4, 6.0 Hz, 1H), 1.15 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 177.0, 172.3, 140.7,
139.8, 136.2, 135.4, 134.0, 132.4, 128.5, 128.0, 127.1, 126.7, 124.3,
122.9, 121.5, 119.6, 117.8, 110.9, 104.4, 102.0, 60.9, 51.9, 45.9, 43.1,
27.5, 14.2; IR (KBr): 3691, 3650, 3057, 3032, 1717, 1686, 1458, 1339,
1264, 1019, 744, 689 cm−1; ESI FTMS exact mass calcd for
</para>
Article
<para sub=“exp”>
− H)− requires m/z 527.0965,

(C29H25BrN2O3
found m/z
527.0975; Enantiomeric excess: 92%, determined by HPLC (Daicel
Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min,
T = 30 °C, 254 nm): tR = 8.37 min (major), tR = 7.15 min (minor).
(2S,3R,4R)-Ethyl 1′-Methyl-2′-oxo-2-phenyl-7′-(triﬂuoro-
methyl)-1,2,4,9-tetrahydrospiro[carbazole-3,3′-indoline]-4-
carboxylate (3ap). Preparative thin layer chromatography: pure
dichloromethane; Reaction time = 15 h; yield: 90% (23.2 mg); >95:5
dr; pale yellow sticky oil; [α]D
20 = +110.9 (c 0.37, Acetone); 1H NMR
(400 MHz, CDCl3) δ 8.10 (s, 1H), 7.55 (d, J = 7.6 Hz, 1H), 7.41 (d, J
= 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 1H), 7.17−7.10 (m, 1H), 7.09−
6.95 (m, 7H), 4.52−4.44 (m, 1H), 4.19−4.12 (m, 1H), 4.11−3.98 (m,
2H), 3.76−3.70 (m, 1H), 3.33−3.28 (m, 3H), 3.15 (dd, J = 16.8, 6.0
Hz, 1H), 1.15 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
177.2, 172.3, 141.4, 139.5, 136.2, 135.3, 131.9, 128.6, 128.4, 128.0,
127.2, 126.7, 126.3, 126.2, 124.8, 122.1, 121.6, 121.1, 119.6, 117.8,
112.1, 111.8, 110.9, 104.4, 61.0, 50.6, 45.6, 43.4, 28.7, 28.6, 27.2, 14.2;
IR (KBr): 3677, 3650, 3032, 1717, 1672, 1437, 1339, 1175, 1023 745
− H)− requires
cm−1; ESI FTMS exact mass calcd for (C30H25F3N2O3
m/z 517.1734,
found m/z 517.1747; Enantiomeric excess: 92%,
determined by HPLC (Daicel Chirapak IA, hexane/isopropanol = 70/
30, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 12.45 min
(major), tR = 16.45 min (minor).
(2S,3R,4R)-Ethyl 1′,7′-Dimethyl-2′-oxo-2-phenyl-1,2,4,9-
tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3aq).
Preparative thin layer chromatography: petroleum ether/ethyl acetate
= 3/1; Reaction time = 15 h; yield: 89% (20.8 mg); >95:5 dr; white
sticky oil; [α]D
20 = +88.7 (c 0.44, Acetone); 1H NMR (400 MHz,
CDCl3) δ 8.10 (s, 1H), 7.39 (d, J = 8.0 Hz, 1H), 7.27−7.24 (m, 1H),
7.20−7.16 (m, 1H), 7.13−7.01 (m, 7H), 6.85−6.76 (m, 2H), 4.52−
4.42 (m, 1H), 4.25−4.11 (m, 1H), 4.10−3.95 (m, 2H), 3.79−3.72 (m,
1H), 3.37 (s, 3H), 3.11 (dd, J = 16.4, 6.0 Hz, 1H), 2.38 (s, 3H), 1.15
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 177.4, 172.5,
141.1, 140.4, 136.2, 135.6, 132.0, 129.8, 128.7, 127.8, 126.8, 126.8,
123.0, 121.7, 121.3, 119.4, 119.1, 117.7, 110.8, 104.8, 60.8, 51.4, 46.0,
43.1, 27.5, 19.1, 14.2; IR (KBr): 3677, 3650, 3032, 1734, 1718, 1658,
1339, 1175, 1023, 745 719 cm−1; ESI FTMS exact mass calcd for
− H)− requires m/z 463.2016, found m/z 463.2015;
(C30H28N2O3
Enantiomeric excess: 94%, determined by HPLC (Daicel Chirapak
OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0 mL/min, T = 30
°C, 254 nm): tR = 11.14 min (major), tR = 8.44 min (minor).
(2S,3R,4R)-4-Benzoyl-1′-methyl-2-phenyl-1,2,4,9-tetra-
hydrospiro[carbazole-3,3′-indolin]-2′-one (3ar). Preparative thin
layer chromatography: pure dichloromethane; Reaction time = 15 h;
20 = −58.0 (c 0.47,
yield: 93% (22.5 mg); >95:5 dr; white sticky oil; [α]D
Acetone); 1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H), 7.68−7.61 (m,
2H), 7.52−7.44 (m, 1H), 7.36−7.30 (m, 2H), 7.27−7.24 (m, 1H),
7.12−7.07 (m, 2H), 7.04−7.00 (m, 5H), 6.97−6.90 (m, 1H), 6.85−
6.78 (m, 2H), 6.66−6.59 (m, 1H), 6.51 (d, J = 8.0 Hz, 1H), 5.21 (s,
1H), 4.64−4.56 (m, 1H), 3.87 (dd, J = 16.4, 11.2 Hz, 1H), 3.19 (dd, J
= 16.4, 6.0 Hz, 1H), 3.11 (s, 3H); 13C NMR (100 MHz, cdcl3) δ
201.5, 177.0, 143.0, 140.0, 138.6, 136.1, 135.9, 132.9, 128.7, 128.5,
128.3, 127.9, 127.7, 126.8, 126.5, 126.2, 121.8, 121.2, 119.2, 117.5,
110.8, 107.5, 105.8, 52.8, 44.6, 43.3, 27.2, 26.0; IR (KBr): 3676, 3650,
3055, 1717, 1699, 1686, 1263, 1207, 1088, 1014, 746 cm−1; ESI FTMS
− H)− requires m/z 481.1911,
exact mass calcd for (C33H26N2O2
found m/z 481.1912; Enantiomeric excess: 92%, determined by HPLC
(Daicel Chirapak OD-H, hexane/isopropanol = 85/15, ﬂow rate 1.0
mL/min, T = 30 °C, 254 nm): tR = 31.95 min (major), tR = 14.02 min
(minor).
(2S,3R,4R)-1′-Methyl-2′-oxo-2-phenyl-1,2,4,9-tetrahydro-
spiro[carbazole-3,3′-indoline]-4-carbonitrile (3as). Preparative
thin layer chromatography: petroleum ether/ethyl acetate = 2/1;
Reaction time = 15 h; yield: 79% (16.0 mg); >95:5 dr; white sticky oil;
20 = +44.8 (c 0.19, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.14
[α]D
(s, 1H), 7.66 (d, J = 7.6 Hz, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.36 (d, J =
8.0 Hz, 1H), 7.25−7.19 (m, 2H), 7.18−7.14 (m, 1H), 7.11−7.02 (m,
6H), 6.64 (d, J = 8.0 Hz, 1H), 4.32 (s, 1H), 3.88−3.86 (m, 1H), 3.85−
3.70 (m, 1H), 3.18 (dd, J = 16.4, 5.6 Hz, 1H), 3.11 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 175., 143.0, 138.9, 136.2, 135.0, 129.0, 128.2,
</para>
3230

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

The Journal of Organic Chemistry
<para sub=“exp”>
128.1, 128.0, 127.4, 125.9, 125.9, 122.5, 122.3, 120.3, 118.4, 117.6,
111.0, 108.0, 101.4, 51.0, 45.0, 32.3, 27.2, 26.2; IR (KBr): 3650, 3301,
3123, 2197, 2015, 1711, 1642, 1333, 1143, 1013, 983 cm−1; ESI FTMS
exact mass calcd for (C27H21N3O − H)− requires m/z 402.1602, found
m/z 402.1611; Enantiomeric excess: 84%, determined by HPLC
(Daicel Chirapak IA, hexane/isopropanol = 70/30, ﬂow rate 1.0 mL/
min, T = 30 °C, 254 nm): tR = 22.14 min (major), tR = 13.11 min
(minor).
(2S,3R,4R)-Ethyl 1′,9-Dimethyl-2′-oxo-2-phenyl-1,2,4,9-
tetrahydrospiro[carbazole-3,3′-indoline]-4-carboxylate (3ja).
Preparative thin layer chromatography: petroleum ether/ethyl acetate
= 3/1; Reaction time = 15 h; yield: 42% (9.9 mg); 80:20 dr; pale
yellow sticky oil; [α]D
20 = +91.8 (c 0.16, Acetone); 1H NMR (400
MHz, CDCl3) δ 7.43 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 7.2 Hz, 1H),
7.30 (d, J = 8.0 Hz, 1H), 7.20−7.13 (m, 1H), 7.13−6.98 (m, 7H),
6.94−6.88 (m, 1H), 6.56 (d, J = 8.0 Hz, 1H), 4.62−4.56 (m, 1H),
4.24−4.15 (m, 1H), 4.11−3.98 (m, 2H), 3.83−3.67 (m, 4H), 3.25−
3.15 (m, 1H), 3.06 (s, 3H), 1.17 (t, J = 7.2 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 176.5, 172.7, 143.3, 140.3, 137.4, 137.1, 129.3, 128.6,
128.2, 127.8, 126.8, 126.4, 125.3, 121.9, 120.8, 119.0, 117.8, 108.9,
107.7, 103.4, 65.9, 60.8, 52.0, 45.7, 43.0, 26.6, 25.9, 15.3, 14.2; IR
(KBr): 3652, 3321, 3027, 1715, 1655, 1321, 1109, 1011, 745 cm−1; ESI
− H)− requires m/z
FTMS exact mass calcd for (C30H28N2O3
463.2016, found m/z 463.2018; Enantiomeric excess: 72%, determined
by HPLC (Daicel Chirapak IA, hexane/isopropanol = 95/5, ﬂow rate
1.0 mL/min, T = 30 °C, 254 nm): tR = 20.89 min (major), tR = 13.18
min (minor).

Procedure and Characterization Data for the Synthesis of
Product 5. LiAlH4 (0.15 mmol) was added to the solution of
compound 3aa (0.1 mmol) in THF (1.5 mL) at room temperature.
Then, this reaction mixture was reﬂuxed at 80 °C overnight. After the
completion of the reaction indicated by TLC, NaOH aqueous (1 M)
was added to the reaction mixture, which was further extracted by
AcOEt to give the organic layer. Then, the organic layer was dried by
anhydrous Na2SO4 and was concentrated under the reduced pressure
to give the residue, which was puriﬁed through ﬂash column
chromatography to aﬀord pure product 5.
(2S,3R,4R)-4-(Hydroxymethyl)-1′-methyl-2-phenyl-1,2,4,9-
tetrahydrospiro[carbazole-3,3′-indolin]-2′-one (5). Flash col-
umn chromatography eluent, petroleum ether/ethyl acetate = 5/1;
Reaction time = 15 h; yield: 92% (37.4 mg); >95:5 dr; white sticky oil;
20 = −12.5 (c 0.61, Acetone); 1H NMR (400 MHz, CDCl3) δ 8.05
[α]D
(s, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.36 (d, J = 8.0 Hz, 1H), 7.25−7.23
(m, 3H), 7.22−7.16 (m, 3H), 7.16−7.12 (m, 2H), 7.11−7.06 (m, 1H),
6.63 (t, J = 7.6 Hz, 1H), 6.50 (d, J = 7.6 Hz, 1H), 4.26−4.20 (m, 1H),
4.09−3.93 (m, 1H), 3.89−3.77 (m, 1H), 3.55−3.48 (m, 1H), 3.28−
3.22 (m, 1H), 3.06 (dd, J = 17.2, 7.6 Hz, 1H), 2.71 (s, 3H), 2.28−2.24
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 152.9, 142.2, 136.7, 134.7,
132.6, 129.7, 128.2, 127.4, 126.7, 125.9, 121.6, 119.6, 119.2, 118.0,
110.8, 109.2, 108.1, 64.1, 63.7, 51.8, 44.9, 43.8, 35.9, 28.2; IR (KBr):
3673, 3651, 3542, 3317, 3234, 2928, 1647, 1628, 1435, 1175, 1016,
− H)−
749, 699 cm−1; ESI FTMS exact mass calcd for (C27H24N2O2
requires m/z 407.1754, found m/z 407.1762; Enantiomeric excess:
94%, determined by HPLC (Daicel Chirapak IA, hexane/isopropanol
= 70/30, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 8.66 min
(major), tR = 8.08 min (minor).
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
Characterization data (including 1H, 13C NMR and HPLC
spectra) for all products, single-crystal data of product 3ao.
This material
is available free of charge via the Internet at
http://pubs.acs.org.

■ AUTHOR INFORMATION

Corresponding Author
*E-mail: fshi@jsnu.edu.cn (F.S.).

Article

Author Contributions
†
The two authors contributed equally to the work.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We are grateful for ﬁnancial support from NSFC (21372002
and 21232007),
Jiangsu Key
Laboratory (K201314), PAPD of Jiangsu province, and the
QingLan Project.

the Open Foundation of

■ REFERENCES
(1) (a) Feng, Y.; Majireck, M. M.; Weinreb, S. M. J. Org. Chem. 2014,
79, 7−24. (b) Busto, E.; Gotor-Fernandez, V.; Gotor, V. J. Org. Chem.
2012, 77, 4842−4848. (c) Guo, K.; Fang, T.-T.; Wang, J.-Y.; Wu, A.-
A.; Wang, Y.-Z.; Jiang, J.; Wu, X.-R.; Song, S.-Y.; Su, W.-J.; Xu, Q.-Y.;
Deng, X.-M. Bioorg. Med. Chem. Lett. 2014, 24, 4995−4998. (d) Patir,
S.; Erturk, E. J. Org. Chem. 2011, 76, 335−338. (e) Tripathy, R.;
Reiboldt, A.; Messina, P. A.; Iqbal, M.; Singh, J.; Bacon, E. R.; Angeles,
T. S.; Yang, S. X.; Albom, M. S.; Robinson, C.; Chang, H.; Ruggeri, B.
A.; Mallamo, J. P. Bioorg. Med. Chem. Lett. 2006, 16, 2158−2162.
(f) Kumari, G.; Nutan; Modi, M.; Gupta, S. K.; Singh, R. K. Eur. J.
Med. Chem. 2011, 46, 1181−1188. (g) Yeung, B. K. S.; Zou, B.;
Rottmann, M.; Lakshminarayana, S. B.; Ang, S. H.; Leong, S. Y.; Tan,
J.; Wong, J.; Keller-Maerki, S.; Fischli, C.; Goh, A.; Schmitt, E. K.;
Krastel, P.; Francotte, E.; Kuhen, K.; Plouffe, D.; Henson, K.; Wagner,
T.; Winzeler, E. A.; Petersen, F.; Brun, R.; Dartois, V.; Diagana, T. T.;
Keller, T. H. J. Med. Chem. 2010, 53, 5155−5164. (h) Murugan, R.;
Anbazhagan, S.; Narayanan, S. S. Eur. J. Med. Chem. 2009, 44, 3272−
3279.
(2) For some examples of enantioselective synthesis of tetrahy-
drocarbazoles: (a) Zhou, S.-L.; Li, J.-L.; Dong, L.; Chen, Y.-C. Org.
Lett. 2011, 13, 5874−5877. (b) Xiao, Y.-C.; Zhou, Q.-Q.; Dong, L.;
Liu, T.-Y.; Chen, Y.-C. Org. Lett. 2012, 14, 5940−5943. (c) Wu, Q.-F.;
Zheng, C.; You, S.-L. Angew. Chem., Int. Ed. 2012, 51, 1680−1683.
(d) Zheng, C.; Wu, Q.-F.; You, S.-L. J. Org. Chem. 2013, 78, 4357−
4365. (e) Xiao, Y.-C.; Yue, C.-Z.; Chen, P.-Q.; Chen, Y.-C. Org. Lett.
2014, 16, 3208−3211. (f) Zhao, R.-R.; Sun, Z.-W.; Mo, M.-J.; Peng, F.-
Z.; Shao, Z.-H. Org. Lett. 2014, 16, 4178−4181.
(3) For some reviews on enantioselective synthesis of spirooxindoles:
(a) Zhou, F.; Liu, Y.-L.; Zhou, J. Adv. Synth. Catal. 2010, 352, 1381−
1407. (b) Klein, J. E. M. N.; Taylor, R. J. K. Eur. J. Org. Chem. 2011,
6821−6841. (c) Shen, K.; Liu, X.; Lin, L.; Feng, X. Chem. Sci. 2012, 3,
327−334. (d) Dou, X.-W.; Lu, Y.-X. Chem.Eur. J. 2012, 18, 8315−
8319. (e) Rios, R. Chem. Soc. Rev. 2012, 41, 1060−1074. (f) Singh, G.
S.; Desta, Z. Y. Chem. Rev. 2012, 112, 6104−6155. (g) Hong, L.;
Wang, R. Adv. Synth. Catal. 2013, 355, 1023−1052. (h) Cheng, D.;
Ishihara, Y.; Tan, B.; Barbas, C. F., III ACS Catal. 2014, 4, 743−762.
(i) Chen, L.; Yin, X.-P.; Wang, C.-H.; Zhou, J. Org. Biomol. Chem.
2014, 12, 6033−6048. (j)
For a prominent example: Tan, B.;
Candeias, N. R.; Barbas, C. F., III Nat. Chem. 2011, 3, 473−477.
(4) (a) Zhu, S.-L.; Ji, S.-J.; Yong, Z. Tetrahedron 2007, 63, 9365−
9372. (b) Abdel-Rahman, A. H.; Keshk, E. M.; Hanna, M. A.; El-Bady,
S. M. Bioorg. Med. Chem. 2004, 12, 2483−2488. (c) Shi, F.; Dai, A.-X.;
Zhang, X.-H.; Jiang, B.; Tu, S.-J. ACS Comb. Sci. 2011, 13, 147−153.
(5) (a) Liu, Y.-K.; Arceo, M. N. E.; Vera, S.; Melchiorre, P. J. Am.
Chem. Soc. 2011, 133, 15212−15218.
For an enantioselective
synthesis of spiro[tetrahydrocarbazole-2,3′-oxindoles]: (b) Tan, B.;
Hernández-Torres, G.; Barbas, C. F., III J. Am. Chem. Soc. 2011, 133,
12354−12357.
(6) For some reviews: (a) Akiyama, T. Chem. Rev. 2007, 107, 5744−
5758. (b) Terada, M. Chem. Commun. 2008, 4097−4112. (c) Terada,
M. Synthesis 2010, 1929−1982. (d) Yu, J.; Shi, F.; Gong, L.-Z. Acc.
Chem. Res. 2011, 44, 1156−1171. (e) Parmar, D.; Sugiono, E.; Raja, S.;
Rueping, M. Chem. Rev. 2014, 114, 9047−9153.
(7) (a) Jones, S. B.; Simmons, B.; MacMillan, D. W. C. J. Am. Chem.
Soc. 2009, 131, 13606−13607. (b) Gioia, C.; Bernardi, L.; Ricci, A.

3231

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

Article

The Journal of Organic Chemistry
Synthesis 2010, 161−170. (c) Wang, X.-F.; Chen, J.-R.; Cao, Y.-J.;
Cheng, H.-G.; Xiao, W.-J. Org. Lett. 2010, 12, 1140−1143. (d) Zheng,
C.-W.; Lu, Y.-P.; Zhang, J.-K.; Chen, X.-K.; Chai, Z.; Ma, W.-Y.; Zhao,
G. Chem.Eur. J. 2010, 16, 5853−5857. (e) Cao, Y.-J.; Cheng, H.-G.;
Lu, L.-Q.; Zhang, J.-J.; Cheng, Y.; Chen, J.-R.; Xiao, W.-J. Adv. Synth.
Catal. 2011, 353, 617−623. (f) Wang, X.-F.; Peng, L.; An, J.; Li, C.;
Yang, Q.-Q.; Lu, L.-Q.; Gu, F.-L.; Xiao, W.-J. Chem.Eur. J. 2011, 17,
6484−6491. (g) Tan, F.; Xiao, C.; Cheng, H.-G.; Wu, W.; Ding, K.-R.;
Xiao, W.-J. Chem.Asian J. 2012, 7, 493−497. (h) Tian, X.; Hofmann,
N.; Melchiorre, P. Angew. Chem., Int. Ed. 2014, 53, 2997−3000.
(i) Ouyang, B.-L.; Yu, T.-T.; Luo, R.-S.; Lu, G. Org. Biomol. Chem.
2014, 12, 4172−4176.
(8) For some examples: (a) Chen, X.-H.; Wei, Q.; Xiao, H.; Luo, S.-
W.; Gong, L.-Z. J. Am. Chem. Soc. 2009, 131, 13819−13825. (b) Wei,
Q.; Gong, L.-Z. Org. Lett. 2010, 12, 1008−1011. (c) Bencivenni, G.;
Wu, L.-Y.; Mazzanti, A.; Giannichi, B.; Pesciaioli, F.; Song, M.-P.;
Bartoli, G.; Melchiorre, P. Angew. Chem., Int. Ed. 2009, 48, 7200−7203.
(d) Cao, Y.-M.; Jiang, X.-X.; Liu, L.-P.; Shen, F.-F.; Zhang, F.-T.;
Wang, R. Angew. Chem., Int. Ed. 2011, 50, 9124−9127. (e) Tan, B.;
Candeias, N. R.; Barbas, C. F., III J. Am. Chem. Soc. 2011, 133, 4672−
4675. (f) Halskov, K. S.; Johansen, T. K.; Davis, R. L.; Steurer, M.;
Jensen, F.; Jøergensen, K. A. J. Am. Chem. Soc. 2012, 134, 12943−
12946. (g) Zeng, X.-F.; Ni, Q.-J.; Raabe, G.; Enders, D. Angew. Chem.,
Int. Ed. 2013, 52, 2977−2980. (h) Shen, L.-T.; Jia, W.-Q.; Ye, S.
Angew. Chem., Int. Ed. 2013, 52, 585−588.
(9) (a) Shi, F.; Xing, G.-J.; Zhu, R.-Y.; Tan, W.; Tu, S.-J. Org. Lett.
2013, 15, 128−131. (b) Shi, F.; Zhu, R.-Y.; Dai, W.; Wang, C.-S.; Tu,
S.-J. Chem.Eur. J. 2014, 20, 2597−2604. (c) Tan, W.; Li, X.; Gong,
Y.-X.; Ge, M.-D.; Shi, F. Chem. Commun. 2014, 50, 15901−15904.
(d) Zhang, Y.-C.; Zhao, J.-J.; Jiang, F.; Sun, S.-B.; Shi, F. Angew. Chem.,
Int. Ed. 2014, 53, 13912−13915.
(10) CCDC 1044162 for 3ao; see the Supporting Information for
details.
(11) For seminal papers: (a) Jia, Y.-X.; Zhong, J.; Zhu, S.-F.; Zhang,
C.-M.; Zhou, Q.-L. Angew. Chem., Int. Ed. 2007, 46, 5565−5567.
(b) Itoh, J.; Fuchibe, K.; Akiyama, T. Angew. Chem., Int. Ed. 2008, 47,
4016−4018.
(12) Storer, R. I.; Carrera, D. E.; Ni, Y.; MacMillan, D. W. C. J. Am.
Chem. Soc. 2006, 128, 84−86.

3232

DOI: 10.1021/acs.joc.5b00198
J. Org. Chem. 2015, 80, 3223−3232

